Dr Ang Peng Tiam

SINGAPORE (Apr 24): TalkMed Group, which provides private healthcare services in the fields of medical oncology through Parkway Cancer Centre in Singapore, reported a 37.2% fall in first quarter earnings to $5.06 million in 1Q18 from $8.39 million in 1Q17

SINGAPORE (Feb 20): TalkMed Group reported 4Q17 earnings fell 19.3% to $8.2 million from $10.2 million a year ago mainly due to a decrease in revenue.

SINGAPORE (Aug 25): Dr Ang Peng Tiam renowned oncologist and CEO of TalkMed Group specialises in treatment and palliative care for people suffering from cancer.

SINGAPORE (June 29): RHB is maintaining its “buy” call on TalkMed Group with a lower target price of 73 cents from $1.03 previously following Wednesday’s news of the eight-month suspension of its CEO, Dr Ang Peng Tiam, starting from July 25.  

SINGAPORE (June 28): Ang Peng Tiam, the executive director and CEO of healthcare company TalkMed Group, has been given an eight-month suspension by the Court of Three Judges on the grounds of professional misconduct.